Archive

Category Archives for "In the News"

Fatty Liver May Affect the Brain, Researchers Say

We love to report good news on the identification and treatment of NAFLD (non-alcoholic fatty liver disease). Often, particularly if in the earliest stages (1 or 2), NAFLD is easily treated via lifestyle changes and sometimes, with medication as recommended by one’s physician. Today, though, the news isn’t all bright. A paper written by Galit […]

Continue reading

GMO v. Non-GMO Study Reveals Surprising Results

When it comes to “good for you,” a chronic condition can change everything you thought you knew about nutrition and food-supported health. For example, consuming oils should mean greater risk of weight gain, and an overweight condition is linked to a variety of health conditions. Yet certain oils may actually help reverse illness when taken in specific […]

Continue reading

Obesity and NAFLD-Promoting Enzyme Isolated by Researchers

In the ongoing global quest to pin down what factors worsen non-alcoholic fatty liver disease (NAFLD), insulin resistance and obesity, German researchers think they may be one enzyme closer. Scientists at he German Institute for Human Nutrition Research (DIfE), a partner of the German Center for Diabetes Research (DZD), have located DPP4, an enzyme they say amped […]

Continue reading

Compound in Olive Oil Could Reverse Insulin Resistance

If you recall the Mediterranean Diet craze, it’s likely you also remember one good thing that came out of it (though overall the diet IS sound): olive oil helped change “fat is bad!” to “some fats and oils have positive health benefits to most people.” Now scientists are saying olive oil may actually help you to […]

Continue reading

Scientists Say This Microbe Could Fight Fatty Liver

As science uncovers more about the gut and how it can impact health, a new study from the University of Jyväskylä, Finland, is claiming a specific bacterium may be coming out the winner against NAFLD. The researchers say Faecalibacterium prausnitzii, a type of bacteria, improved NAFLD in laboratory mice when administered orally. The strain had previously been found […]

Continue reading

New Trial in the Works for FLDG-Fighting “Cocktail”

Exciting news: based on prior successful research, scientists in Sweden are planning a new trial combining components expected to have a positive effect on Type II Diabetes and NAFLD. Researchers at the KTH Royal Institute of Technology’s Science for Life Laboratory (SciLifeLab) research center and Gothenburg University, Sweden, say they have isolated constituents that appear […]

Continue reading

German Scientists: “One Cheat Meal CAN Hurt”

It’s something few of us will want to hear: Scientists at the German Diabetes Center, Dusseldorf and Helhmoltz Center, Munich are making the claim that just one over-fat meal really can harm us. According to a study published in February in the Journal of Clinical Investigation, research participants of a normal weight given a palm oil-laden […]

Continue reading

Antioxidant in Kiwi Could Protect Liver, Study Says

Constituents found in soil, in fruits such as kiwi and, fascinatingly, in breast milk may have protective qualities against inflammation of the liver and the future development and progression of NAFLD, according to a new study. The paper, “Early PQQ Supplementation Has Persistent Long-Term Protective Effects on Developmental Programming of Hepatic Lipotoxicity and Inflammation in […]

Continue reading

Predicting Mortality Risk in NAFLD Patients

**   Before we begin: No, that was not a “grabber” headline. In fact, it’s our stance that NAFLD can, for many, many people, be effectively treated, and good health restored for many NAFLD individuals; we’ve seen it happen. With that said, there is a slightly elevated mortality risk in people diagnosed with NAFLD. Among […]

Continue reading

Texas Researchers Call for Study Volunteers

Clinical Trials of Texas, San Antonio researchers have put out a call for individuals  to take place in an NAFLD study. Applicants will be chosen from among a group who have or suspect they may have metabolic syndrome or conditions involved in metabolic syndrome, according to Douglas Denham, medical director of the pending study. “We […]

Continue reading
>
Scroll Up